Detalles de la búsqueda
1.
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Cardiovasc Diabetol
; 22(1): 233, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653496
2.
Rare coding variants in RCN3 are associated with blood pressure.
BMC Genomics
; 23(1): 148, 2022 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35183128
3.
Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries.
BMC Med
; 20(1): 249, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35831899
4.
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Cardiovasc Diabetol
; 21(1): 158, 2022 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35996147
5.
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Diabetes Obes Metab
; 24(4): 704-712, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984808
6.
Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective.
Diabetes Obes Metab
; 23(1): 3-17, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32991073
7.
Shorter (GT)n repeats in the haem-oxygenase 1 gene promoter are associated with better mid-term survival in subjects with coronary artery disease and abnormal ejection fraction.
Biomarkers
; 26(8): 732-736, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34634993
8.
Subjects with coronary artery disease and reduced ejection fraction have longer (GT)n repeats in the heme-oxygenase 1 gene promoter.
Heart Vessels
; 36(5): 615-620, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388910
9.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet
; 394(10193): 121-130, 2019 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31189511
10.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Lancet
; 394(10193): 131-138, 2019 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31189509
11.
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
N Engl J Med
; 377(3): 211-221, 2017 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28538136
12.
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Cardiovasc Diabetol
; 19(1): 199, 2020 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239067
13.
Hypoglycaemic episodes increase the risk of ventricular arrhythmia and sudden cardiac arrest in patients with type 2 diabetes-A nationwide cohort study.
Diabetes Metab Res Rev
; 36(2): e3226, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31655001
14.
Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register.
Diabetes Obes Metab
; 22(4): 669-679, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903728
15.
Subjects with microvascular angina have longer GT repeats polymorphism in the haem oxygenase-1 gene promoter.
Biomarkers
; 25(2): 144-148, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31916865
16.
IMPLEMENTATION OF AN ELECTRONIC DASHBOARD WITH A REMOTE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC MANAGEMENT AMONG HOSPITALIZED ADULTS.
Endocr Pract
; 26(2): 179-191, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31557078
17.
Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels.
Hum Mol Genet
; 26(9): 1770-1784, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28334899
18.
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
Diabetes Obes Metab
; 21(11): 2354-2367, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31264765
19.
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.
Diabetes Obes Metab
; 21(3): 499-508, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30284349
20.
Fine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci.
Hum Mol Genet
; 25(24): 5500-5512, 2016 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28426890